Medicus Pharma Ltd. MDCX
Set alert
1.95 USD +0.07 +3.72%
As of Nov 2, 12:51 PM ET
1.79 Day range 1.98
1.79 52-week range 127.50
- YTD
- -97.45%
- 1 year
- -98.40%
- Open
- 1.86
- Prev close
- 1.88
- Mkt cap
- 3.70M
- Vol
- 24.98K
- Avg vol
- 108.20K
- EPS
- -119.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.79
- High
- 1.98
- Forward P/E
- 0.00
- Beta
- 0.00
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 2.52
- 200-d avg
- 2.52
- 1y target
- 7.81
Financial health
Altman Z-Score
-10.81 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 2
- Return on Equity 5
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -0.8×
FY 2021 5y median -5.4× FY 2025
P/S 0.0×
FY 2021 5y median 0.0× FY 2025
P/B -391×
FY 2021 5y median -1.8× FY 2025
P/FCF -1.2×
FY 2021 5y median -5.1× FY 2025
EV/EBITDA -0.9×
FY 2021 5y median -2.2× FY 2025
EV/Sales 0.0×
FY 2021 5y median 0.0× FY 2025
FCF Yield -86.1%
FY 2021 5y median -19.4% FY 2025
Profitability
Gross Margin 0.0%
FY 2021 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2021 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2021 5y median 0.0% FY 2025
ROE 37549.8%
FY 2021 5y median 13.9% FY 2025
ROIC -452.4%
FY 2021 5y median -323.4% FY 2025
ROA -252.1%
FY 2021 5y median -280.8% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2021 FY 2025
Operating Income -64.1%
FY 2021 FY 2025
EPS (diluted) -184.1%
FY 2021 FY 2025
Free Cash Flow -122.3%
FY 2021 FY 2025
Financial Health
Current Ratio 1.0×
FY 2021 5y median 1.0× FY 2025
Quick Ratio 1.0×
FY 2021 5y median 1.0× FY 2025
Debt / Equity -59.1×
FY 2021 5y median -0.1× FY 2025
Net Debt / EBITDA 0.2×
FY 2021 5y median -0.3× FY 2025
Interest Coverage -130×
FY 2021 5y median -12.5× FY 2025
Dividends
Dividend Yield 0.0%
FY 2021 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2021 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31